These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 17339588
1. Age at onset determines the occurrence of the progressive phase of multiple sclerosis. Stankoff B, Mrejen S, Tourbah A, Fontaine B, Lyon-Caen O, Lubetzki C, Rosenheim M. Neurology; 2007 Mar 06; 68(10):779-81. PubMed ID: 17339588 [Abstract] [Full Text] [Related]
2. Natural history of multiple sclerosis: a unifying concept. Confavreux C, Vukusic S. Brain; 2006 Mar 06; 129(Pt 3):606-16. PubMed ID: 16415308 [Abstract] [Full Text] [Related]
3. Is late-onset multiple sclerosis associated with a worse outcome? Tremlett H, Devonshire V. Neurology; 2006 Sep 26; 67(6):954-9. PubMed ID: 17000960 [Abstract] [Full Text] [Related]
4. Cigarette smoking and progression in multiple sclerosis. Koch M, van Harten A, Uyttenboogaart M, De Keyser J. Neurology; 2007 Oct 09; 69(15):1515-20. PubMed ID: 17923613 [Abstract] [Full Text] [Related]
5. Progression in multiple sclerosis: further evidence of an age dependent process. Koch M, Mostert J, Heersema D, De Keyser J. J Neurol Sci; 2007 Apr 15; 255(1-2):35-41. PubMed ID: 17331540 [Abstract] [Full Text] [Related]
9. Timing of birth and disease progression in multiple sclerosis. Koch M, De Keyser J, Tremlett H. Mult Scler; 2008 Jul 15; 14(6):793-8. PubMed ID: 18573829 [Abstract] [Full Text] [Related]
10. Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation. Veugelers PJ, Fisk JD, Brown MG, Stadnyk K, Sketris IS, Murray TJ, Bhan V. Mult Scler; 2009 Nov 15; 15(11):1286-94. PubMed ID: 19965558 [Abstract] [Full Text] [Related]
11. The natural history of multiple sclerosis with childhood onset. Renoux C, Vukusic S, Confavreux C. Clin Neurol Neurosurg; 2008 Nov 15; 110(9):897-904. PubMed ID: 18534742 [Abstract] [Full Text] [Related]
12. The natural history of primary progressive multiple sclerosis. Koch M, Kingwell E, Rieckmann P, Tremlett H. Neurology; 2009 Dec 08; 73(23):1996-2002. PubMed ID: 19996074 [Abstract] [Full Text] [Related]
13. Factors associated with the risk of secondary progression in multiple sclerosis. Koch M, Uyttenboogaart M, van Harten A, De Keyser J. Mult Scler; 2008 Jul 08; 14(6):799-803. PubMed ID: 18573840 [Abstract] [Full Text] [Related]
14. Clinical characteristics of multiple sclerosis in Lebanon. Yamout B, Barada W, Tohme RA, Mehio-Sibai A, Khalifeh R, El-Hajj T. J Neurol Sci; 2008 Jul 15; 270(1-2):88-93. PubMed ID: 18367208 [Abstract] [Full Text] [Related]
15. Age at disability milestones in multiple sclerosis. Confavreux C, Vukusic S. Brain; 2006 Mar 15; 129(Pt 3):595-605. PubMed ID: 16415309 [Abstract] [Full Text] [Related]
17. The natural history of primary progressive MS in British Columbia, Canada. Tremlett H, Paty D, Devonshire V. Neurology; 2005 Dec 27; 65(12):1919-23. PubMed ID: 16380613 [Abstract] [Full Text] [Related]
18. Natural history of multiple sclerosis: risk factors and prognostic indicators. Vukusic S, Confavreux C. Curr Opin Neurol; 2007 Jun 27; 20(3):269-74. PubMed ID: 17495619 [Abstract] [Full Text] [Related]
20. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population. El-Salem K, Khader Y. Clin Neurol Neurosurg; 2007 Jan 27; 109(1):32-7. PubMed ID: 16870328 [Abstract] [Full Text] [Related] Page: [Next] [New Search]